- Home
- EZPW vs ABUS Comparison
EZPW vs ABUS Comparison
Compare EZPW & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EZPW
- ABUS
- Stock Information
- Founded
- EZPW 1989
- ABUS N/A
- Country
- EZPW United States
- ABUS United States
- Employees
- EZPW N/A
- ABUS N/A
- Industry
- EZPW Other Specialty Stores
- ABUS Biotechnology: Pharmaceutical Preparations
- Sector
- EZPW Consumer Discretionary
- ABUS Health Care
- Exchange
- EZPW Nasdaq
- ABUS Nasdaq
- Market Cap
- EZPW 661.2M
- ABUS 629.1M
- IPO Year
- EZPW 1991
- ABUS N/A
- Fundamental
- Price
- EZPW $12.30
- ABUS $3.20
- Analyst Decision
- EZPW Buy
- ABUS Strong Buy
- Analyst Count
- EZPW 2
- ABUS 4
- Target Price
- EZPW $16.00
- ABUS $5.50
- AVG Volume (30 Days)
- EZPW 427.1K
- ABUS 919.1K
- Earning Date
- EZPW 01-29-2025
- ABUS 02-27-2025
- Dividend Yield
- EZPW N/A
- ABUS N/A
- EPS Growth
- EZPW 108.21
- ABUS N/A
- EPS
- EZPW 1.10
- ABUS N/A
- Revenue
- EZPW $1,161,602,000.00
- ABUS $6,742,000.00
- Revenue This Year
- EZPW $9.59
- ABUS N/A
- Revenue Next Year
- EZPW $6.36
- ABUS N/A
- P/E Ratio
- EZPW $11.16
- ABUS N/A
- Revenue Growth
- EZPW 10.73
- ABUS N/A
- 52 Week Low
- EZPW $8.20
- ABUS $2.27
- 52 Week High
- EZPW $12.85
- ABUS $4.72
- Technical
- Relative Strength Index (RSI)
- EZPW 56.79
- ABUS 42.47
- Support Level
- EZPW $11.69
- ABUS $3.16
- Resistance Level
- EZPW $12.45
- ABUS $3.38
- Average True Range (ATR)
- EZPW 0.27
- ABUS 0.15
- MACD
- EZPW 0.02
- ABUS 0.01
- Stochastic Oscillator
- EZPW 79.22
- ABUS 19.05
About EZPW EZCORP Inc. Non Voting
EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buy and sell second-hand goods. The operating segments of the company are us Pawn, Latin America Pawn, and other international. us Pawn segment includes all pawn activities in the United States. Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales which are primarily collateral forfeited from pawn lending operations and used merchandise purchased from the customers.
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.